Last update 26 Apr 2025

Olodaterol/BI-54903(Boehringer Ingelheim)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
olodaterol/BI-54903(Boehringer Ingelheim)
Target
β2-adrenergic receptor
Action
agonists
Mechanism
β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Therapeutic Areas
Immune System DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
Asthma
Originator Organization
Boehringer Ingelheim International GmbH
Active Organization-
Inactive Organization
Boehringer Ingelheim International GmbH
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H26N2O5
InChIKeyCOUYJEVMBVSIHV-SFHVURJKSA-N
CAS Registry868049-49-4

Related

1
Clinical Trials associated with Olodaterol/BI-54903(Boehringer Ingelheim)
NCT01428622
/ WithdrawnPhase 2
Single Dose Comparison of 3 Doses of Olodaterol in Double Fixed Dose Combination With BI54903 vs. 3 Doses of Olodaterol Mono in Free Combination
100 Clinical Results associated with Olodaterol/BI-54903(Boehringer Ingelheim)
Login to view more data
100 Translational Medicine associated with Olodaterol/BI-54903(Boehringer Ingelheim)
Login to view more data
100 Patents (Medical) associated with Olodaterol/BI-54903(Boehringer Ingelheim)
Login to view more data
100 Deals associated with Olodaterol/BI-54903(Boehringer Ingelheim)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AsthmaPhase 1
Europe
Boehringer Ingelheim International GmbH
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free